2017 MIPS Quality Measures

All 2017 MIPS registry quality measures can be reported with MDinteractive.  

Each provider will need to submit data on at >= 50% of applicable Medicare and non-Medicare patients on at least 6 quality measures. 

To report measures via registry, please create an account with MDinteractive.  There is no upfront fee associated with creating an account.

You will need to contact MDinteractive (800.634.4731 or support@mdinteractive.com)  if one of the available 2017 registry measures is missing in your account. 

Please check 2017 Measure Specifications for Claims and Registry Release Notes to see changes to existing measures made since the release of the 2016 PQRS Measure Specifications. Please use this Code Master file, if you are looking for the individual MIPS measures that apply to the specific ICD10 and/or CPT codes that you use to bill Medicare.

#1. Diabetes: Hemoglobin A1c Poor Control Outcome

Measure Description pdf.png (CMS)

#5. Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)

Measure Description pdf.png (CMS)

#6. Coronary Artery Disease (CAD): Antiplatelet Therapy

Measure Description pdf.png (CMS)

#7. Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%)

Measure Description pdf.png (CMS)

#8. Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

Measure Description pdf.png (CMS)

#12. Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation

Measure Description pdf.png (CMS)

#14. Age-Related Macular Degeneration (AMD): Dilated Macular Examination

Measure Description pdf.png (CMS)

#19. Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care High Priority

Measure Description pdf.png (CMS)

#21. Perioperative Care: Selection of Prophylactic Antibiotic – First OR Second Generation Cephalosporin High Priority

Measure Description pdf.png (CMS)

#23. Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) High Priority

Measure Description pdf.png (CMS)

#24. Communication with the Physician or Other Clinician Managing On-going Care Post-Fracture for Men and Women Aged 50 Years and Older High Priority

Measure Description pdf.png (CMS)

#32. Stroke and Stroke Rehabilitation: Discharged on Antithrombotic Therapy

Measure Description pdf.png (CMS)

#39. Screening for Osteoporosis for Women Aged 65-85 Years of Age

Measure Description pdf.png (CMS)

#43. Coronary Artery Bypass Graft (CABG): Use of Internal Mammary Artery (IMA) in Patients with Isolated CABG Surgery

Measure Description pdf.png (CMS)

#44. Coronary Artery Bypass Graft (CABG): Preoperative Beta-Blocker in Patients with Isolated CABG Surgery

Measure Description pdf.png (CMS)

#46. Medication Reconciliation Post-Discharge High Priority

Measure Description pdf.png (CMS)

#47. Care Plan High Priority

Measure Description pdf.png (CMS)

#48. Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older

Measure Description pdf.png (CMS)

#50. Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and Older High Priority

Measure Description pdf.png (CMS)

#51. Chronic Obstructive Pulmonary Disease (COPD): Spirometry Evaluation

Measure Description pdf.png (CMS)

#52. Chronic Obstructive Pulmonary Disease (COPD): Inhaled Bronchodilator Therapy

Measure Description pdf.png (CMS)

#65. Appropriate Treatment for Children with Upper Respiratory Infection (URI) High Priority

Measure Description pdf.png (CMS)

#66. Appropriate Testing for Children with Pharyngitis High Priority

Measure Description pdf.png (CMS)

#67. Hematology: Myelodysplastic Syndrome (MDS) and Acute Leukemias: Baseline Cytogenetic Testing Performed on Bone Marrow

Measure Description pdf.png (CMS)

#68. Hematology: Myelodysplastic Syndrome (MDS): Documentation of Iron Stores in Patients Receiving Erythropoietin Therapy

Measure Description pdf.png (CMS)

#69. Hematology: Multiple Myeloma: Treatment with Bisphosphonates

Measure Description pdf.png (CMS)

#70. Hematology: Chronic Lymphocytic Leukemia (CLL): Baseline Flow Cytometry

Measure Description pdf.png (CMS)

#76. Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections High Priority

Measure Description pdf.png (CMS)

#91. Acute Otitis Externa (AOE): Topical Therapy High Priority

Measure Description pdf.png (CMS)

#93. Acute Otitis Externa (AOE): Systemic Antimicrobial Therapy – Avoidance of Inappropriate Use High Priority

Measure Description pdf.png (CMS)

#99 . Breast Cancer Resection Pathology Reporting: pT Category (Primary Tumor) and pN Category (Regional Lymph Nodes) with Histologic Grade

Measure Description pdf.png (CMS)

#100. Colorectal Cancer Resection Pathology Reporting: pT Category (Primary Tumor) and pN Category (Regional Lymph Nodes) with Histologic Grade

Measure Description pdf.png (CMS)

#102. Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients High Priority

Measure Description pdf.png (CMS)

#104. Prostate Cancer: Adjuvant Hormonal Therapy for High Risk or Very High Risk Prostate Cancer

Measure Description pdf.png (CMS)

#109. Osteoarthritis (OA): Function and Pain Assessment High Priority

Measure Description pdf.png (CMS)

#110. Preventive Care and Screening: Influenza Immunization

Measure Description pdf.png (CMS)

#111. Pneumonia Vaccination Status for Older Adults

Measure Description pdf.png (CMS)

#112. Breast Cancer Screening

Measure Description pdf.png (CMS)

#113. Colorectal Cancer Screening

Measure Description pdf.png (CMS)

#116. Avoidance of Antibiotic Treatment in Adults With Acute Bronchitis High Priority

Measure Description pdf.png (CMS)

#117. Diabetes: Eye Exam

Measure Description pdf.png (CMS)

#118. Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF < 40%)

Measure Description pdf.png (CMS)

#119. Diabetes: Medical Attention for Nephropathy

Measure Description pdf.png (CMS)

#122. Adult Kidney Disease: Blood Pressure Management Outcome

Measure Description pdf.png (CMS)

#126. Diabetes Mellitus: Diabetic Foot and Ankle Care, Peripheral Neuropathy – Neurological Evaluation

Measure Description pdf.png (CMS)

#127. Diabetes Mellitus: Diabetic Foot and Ankle Care, Ulcer Prevention – Evaluation of Footwear

Measure Description pdf.png (CMS)

#128. Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan

Measure Description pdf.png (CMS)

#130. Documentation of Current Medications in the Medical Record High Priority

Measure Description pdf.png (CMS)

#131. Pain Assessment and Follow-Up High Priority

Measure Description pdf.png (CMS)

#134. Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan

Measure Description pdf.png (CMS)

#137: Melanoma: Continuity of Care – Recall System High Priority

Measure Description pdf.png (CMS)

#138: Melanoma: Coordination of Care High Priority

Measure Description pdf.png (CMS)

#140. Age-Related Macular Degeneration (AMD): Counseling on Antioxidant Supplement

Measure Description pdf.png (CMS)

#141. Primary Open-Angle Glaucoma (POAG): Reduction of Intraocular Pressure (IOP) by 15% OR Documentation of a Plan of Care Outcome

Measure Description pdf.png (CMS)

#143: Oncology: Medical and Radiation – Pain Intensity Quantified High Priority

Measure Description pdf.png (CMS)

#144: Oncology: Medical and Radiation – Plan of Care for Pain High Priority

Measure Description pdf.png (CMS)

#145. Exposure Time Reported for Procedures Using Fluoroscopy High Priority

Measure Description pdf.png (CMS)

#146. Radiology: Inappropriate Use of “Probably Benign” Assessment Category in Screening Mammograms High Priority

Measure Description pdf.png (CMS)

#147. Nuclear Medicine: Correlation with Existing Imaging Studies for All Patients Undergoing Bone Scintigraphy High Priority

Measure Description pdf.png (CMS)

#154. Falls: Risk Assessment High Priority

Measure Description pdf.png (CMS)

#155. Falls: Plan of Care High Priority

Measure Description pdf.png (CMS)

#156. Oncology: Radiation Dose Limits to Normal Tissues High Priority

Measure Description pdf.png (CMS)

#164. Coronary Artery Bypass Graft (CABG): Prolonged Intubation Outcome

Measure Description pdf.png (CMS)

#165. Coronary Artery Bypass Graft (CABG): Deep Sternal Wound Infection Rate Outcome

Measure Description pdf.png (CMS)

#166. Coronary Artery Bypass Graft (CABG): Stroke Outcome

Measure Description pdf.png (CMS)

#167. Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure Outcome

Measure Description pdf.png (CMS)

#168. Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration Outcome

Measure Description pdf.png (CMS)

#176. Rheumatoid Arthritis (RA): Tuberculosis Screening

Measure Description pdf.png (CMS)

#177. Rheumatoid Arthritis (RA): Periodic Assessment of Disease Activity

Measure Description pdf.png (CMS)

#178. Rheumatoid Arthritis (RA): Functional Status Assessment

Measure Description pdf.png (CMS)

#179. Rheumatoid Arthritis (RA): Assessment and Classification of Disease Prognosis

Measure Description pdf.png (CMS)

#180. Rheumatoid Arthritis (RA): Glucocorticoid Management

Measure Description pdf.png (CMS)

#181. Elder Maltreatment Screen and Follow-Up Plan High Priority

Measure Description pdf.png (CMS)

#182. Functional Outcome Assessment High Priority

Measure Description pdf.png (CMS)

#185. Colonoscopy Interval for Patients with a History of Adenomatous Polyps – Avoidance of Inappropriate Use High Priority

Measure Description pdf.png (CMS)

#187. Stroke and Stroke Rehabilitation: Thrombolytic Therapy

Measure Description pdf.png (CMS)

#191. Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery Outcome

Measure Description pdf.png (CMS)

#192. Cataracts: Complications within 30 Days Following Cataract Surgery Requiring Additional Surgical Procedures Outcome

Measure Description pdf.png (CMS)

#195. Radiology: Stenosis Measurement in Carotid Imaging Reports

Measure Description pdf.png (CMS)

#204. Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic

Measure Description pdf.png (CMS)

#205. HIV/AIDS: Sexually Transmitted Disease Screening for Chlamydia, Gonorrhea, and Syphilis

Measure Description pdf.png (CMS)

#217. Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Knee Impairments Outcome

Measure Description pdf.png (CMS)

#218. Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Hip Impairments Outcome

Measure Description pdf.png (CMS)

#219. Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Lower Leg, Foot or Ankle Impairments Outcome

Measure Description pdf.png (CMS)

#220. Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Lumbar Spine Impairments Outcome

Measure Description pdf.png (CMS)

#221. Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Shoulder Impairments Outcome

Measure Description pdf.png (CMS)

#222. Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Elbow, Wrist or Hand Impairments Outcome

Measure Description pdf.png (CMS)

#223. Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Neck, Cranium, Mandible, Thoracic Spine, Ribs, or Other General Orthopedic Impairments Outcome

Measure Description pdf.png (CMS)

#224: Melanoma: Overutilization of Imaging Studies in Melanoma High Priority

Measure Description pdf.png (CMS)

#225. Radiology: Reminder System for Screening Mammograms High Priority

Measure Description pdf.png (CMS)

#226. Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

Measure Description pdf.png (CMS)

#236. Controlling High Blood Pressure Outcome

Measure Description pdf.png (CMS)

#238. Use of High-Risk Medications in the Elderly High Priority

Measure Description pdf.png (CMS)

#243. Cardiac Rehabilitation Patient Referral from an Outpatient Setting High Priority

Measure Description pdf.png (CMS)

#249. Barrett's Esophagus

Measure Description pdf.png (CMS)

#250. Radical Prostatectomy Pathology Reporting

Measure Description pdf.png (CMS)

#251. Quantitative Immunohistochemical (IHC) Evaluation of Human Epidermal Growth Factor Receptor 2 Testing (HER2) for Breast Cancer Patients

Measure Description pdf.png (CMS)

#254. Ultrasound Determination of Pregnancy Location for Pregnant Patients with Abdominal Pain

Measure Description pdf.png (CMS)

#255. Rh Immunoglobulin (Rhogam) for Rh-Negative Pregnant Women at Risk of Fetal Blood Exposure

Measure Description pdf.png (CMS)

#257. Statin Therapy at Discharge after Lower Extremity Bypass (LEB)

Measure Description pdf.png (CMS)

#258. Rate of Open Repair of Small or Moderate Non-Ruptured Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post-Operative Day #7) Outcome

Measure Description pdf.png (CMS)

#259. Rate of Elective Endovascular Aortic Repair (EVAR) of Small or Moderate Abdominal Aortic Aneurysms (AAA) without Major Complications (Discharged to Home by Post Operative Day #2) Outcome

Measure Description pdf.png (CMS)

#260. Rate of Carotid Endarterectomy (CEA) for Asymptomatic Patients, without Major Complications (Discharged to Home by Post-Operative Day #2) Outcome

Measure Description pdf.png (CMS)

#261. Referral for Otologic Evaluation for Patients with Acute or Chronic Dizziness High Priority

Measure Description pdf.png (CMS)

#262. Image Confirmation of Successful Excision of Image-Localized Breast Lesion High Priority

Measure Description pdf.png (CMS)

#263. Preoperative Diagnosis of Breast Cancer

Measure Description pdf.png (CMS)

#264. Sentinel Lymph Node Biopsy for Invasive Breast Cancer

Measure Description pdf.png (CMS)

#265: Biopsy Follow-Up High Priority

Measure Description pdf.png (CMS)

#268. Epilepsy: Counseling for Women of Childbearing Potential with Epilepsy

Measure Description pdf.png (CMS)

#271. Inflammatory Bowel Disease (IBD): Preventive Care: Corticosteroid Related Iatrogenic Injury

Measure Description pdf.png (CMS)

#275. Inflammatory Bowel Disease (IBD): Assessment of Hepatitis B Virus (HBV) Status Before Initiating Anti-TNF (Tumor Necrosis Factor) Therapy

Measure Description pdf.png (CMS)

#276. Sleep Apnea: Assessment of Sleep Symptoms

Measure Description pdf.png (CMS)

#277. Sleep Apnea: Severity Assessment at Initial Diagnosis

Measure Description pdf.png (CMS)

#278. Sleep Apnea: Positive Airway Pressure Therapy Prescribed

Measure Description pdf.png (CMS)

#279. Sleep Apnea: Assessment of Adherence to Positive Airway Pressure Therapy

Measure Description pdf.png (CMS)

#282. Dementia: Functional Status Assessment

Measure Description pdf.png (CMS)

#283. Dementia: Neuropsychiatric Symptom Assessment

Measure Description pdf.png (CMS)

#284. Dementia: Management of Neuropsychiatric Symptoms

Measure Description pdf.png (CMS)

#286. Dementia: Counseling Regarding Safety Concerns High Priority

Measure Description pdf.png (CMS)

#288. Dementia: Caregiver Education and Support High Priority

Measure Description pdf.png (CMS)

#290. Parkinson’s Disease: Psychiatric Symptoms Assessment for Patients with Parkinson’s Disease

Measure Description pdf.png (CMS)

#291. Parkinson’s Disease: Cognitive Impairment or Dysfunction Assessment

Measure Description pdf.png (CMS)

#293. Parkinson’s Disease: Rehabilitative Therapy Options High Priority

Measure Description pdf.png (CMS)

#294. Parkinson’s Disease: Parkinson’s Disease Medical and Surgical Treatment Options Reviewed High Priority

Measure Description pdf.png (CMS)

#303. Cataracts: Improvement in Patient’s Visual Function within 90 Days Following Cataract Surgery Outcome

Measure Description pdf.png (CMS)

#304. Cataracts: Patient Satisfaction within 90 Days Following Cataract Surgery Outcome

Measure Description pdf.png (CMS)

#317. Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented

Measure Description pdf.png (CMS)

#320. Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk Patients High Priority

Measure Description pdf.png (CMS)

#322. Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low Risk Surgery Patients High Priority

Measure Description pdf.png (CMS)

#323. Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Routine Testing After Percutaneous Coronary Intervention (PCI) High Priority

Measure Description pdf.png (CMS)

#324. Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Testing in Asymptomatic, Low-Risk Patients High Priority

Measure Description pdf.png (CMS)

#325. Adult Major Depressive Disorder (MDD): Coordination of Care of Patients with Specific Comorbid Conditions High Priority

Measure Description pdf.png (CMS)

 #326. Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy

Measure Description pdf.png (CMS)

#327. Pediatric Kidney Disease: Adequacy of Volume Management High Priority

Measure Description pdf.png (CMS)

#328. Pediatric Kidney Disease: ESRD Patients Receiving Dialysis: Hemoglobin Level < 10g/dL Outcome

Measure Description pdf.png (CMS)

#329. Adult Kidney Disease: Catheter Use at Initiation of Hemodialysis Outcome

Measure Description pdf.png (CMS)

#330. Adult Kidney Disease: Catheter Use for Greater Than or Equal to 90 Days Outcome

Measure Description pdf.png (CMS)

#331. Adult Sinusitis: Antibiotic Prescribed for Acute Sinusitis (Overuse) High Priority

Measure Description pdf.png (CMS)

#332. Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin With or Without Clavulanate Prescribed for Patients with Acute Bacterial Sinusitis (Appropriate Use) High Priority

Measure Description pdf.png (CMS)

#333. Adult Sinusitis: Computerized Tomography (CT) for Acute Sinusitis (Overuse) High Priority

Measure Description pdf.png (CMS)

 #334. Adult Sinusitis: More than One Computerized Tomography (CT) Scan Within 90 Days for Chronic Sinusitis (Overuse) High Priority

Measure Description pdf.png (CMS)

 #335. Maternity Care: Elective Delivery or Early Induction Without Medical Indication at = 37 and < 39 Weeks (Overuse) Outcome

Measure Description pdf.png (CMS)

 #336. Maternity Care: Post-Partum Follow-Up and Care Coordination High Priority

Measure Description pdf.png (CMS)

 #337. Tuberculosis Prevention for Psoriasis,Psoriatic Arthritis and Rheumatoid Arthritis Patients on a Biological Immune Response Modifier

Measure Description pdf.png (CMS)

 #338. HIV Viral Load Suppression Outcome

Measure Description pdf.png (CMS)

 #340. HIV Medical Visit Frequency High Priority

Measure Description pdf.png (CMS)

 #342. Pain Brought Under Control Within 48 Hours Outcome

Measure Description pdf.png (CMS)

 #343. Screening Colonoscopy Adenoma Detection Rate Outcome

Measure Description pdf.png (CMS)

 #344. Rate of Carotid Artery Stenting (CAS) for Asymptomatic Patients, Without Major Complications (Discharged to Home by Post-Operative Day #2) Outcome

Measure Description pdf.png (CMS)

 #345. Rate of Postoperative Stroke or Death in Asymptomatic Patients Undergoing Carotid Artery Stenting (CAS): Outcome

Measure Description pdf.png (CMS)

#346. Rate of Postoperative Stroke or Death in Asymptomatic Patients Undergoing Carotid Endarterectomy (CEA) Outcome

Measure Description pdf.png (CMS)

#347. Rate of Endovascular Aneurysm Repair (EVAR) of Small or Moderate Non-Ruptured Abdominal Aortic Aneurysms (AAA) Who Die While in Hospital Outcome

Measure Description pdf.png (CMS)

#348. HRS-3: Implantable Cardioverter-Defibrillator (ICD) Complications Rate Outcome

Measure Description pdf.png (CMS)

#350. Total Knee Replacement: Shared Decision-Making: Trial of Conservative (Non-surgical) Therapy High Priority

Measure Description pdf.png (CMS)

#351. Total Knee Replacement: Venous Thromboembolic and Cardiovascular Risk Evaluation High Priority

Measure Description pdf.png (CMS)

#352. Total Knee Replacement: Preoperative Antibiotic Infusion with Proximal Tourniquet High Priority

Measure Description pdf.png (CMS)

#353. Total Knee Replacement: Identification of Implanted Prosthesis in Operative Report High Priority

Measure Description pdf.png (CMS)

#354. Anastomotic Leak Intervention Outcome

Measure Description pdf.png (CMS)

#355. Unplanned Reoperation within the 30 Day Postoperative Period Outcome

Measure Description pdf.png (CMS)

#356. Unplanned Hospital Readmission within 30 Days of Principal Procedure Outcome

Measure Description pdf.png (CMS)

#357. Surgical Site Infection (SSI) Outcome

Measure Description pdf.png (CMS)

#358. Patient-centered Surgical Risk Assessment and Communication High Priority

Measure Description (CMS) 

#359. Optimizing Patient Exposure to Ionizing Radiation: Utilization of a Standardized Nomenclature for Computed Tomography (CT) Imaging Description High Priority

Measure Description pdf.png (CMS)

#360.Optimizing Patient Exposure to Ionizing Radiation: Count of Potential High Dose Radiation Imaging Studies: Computed Tomography (CT) and Cardiac Nuclear Medicine Studies High Priority

Measure Description pdf.png (CMS)

#361. Optimizing Patient Exposure to Ionizing Radiation: Reporting to a Radiation Dose Index Registry High Priority

Measure Description pdf.png (CMS)

#362. Optimizing Patient Exposure to Ionizing Radiation: Computed Tomography (CT) Images Available for Patient Follow-up and Comparison Purposes High Priority

Measure Description pdf.png (CMS)

#363. Optimizing Patient Exposure to Ionizing Radiation: Search for Prior Computed Tomography (CT) Studies Through a Secure, Authorized, Media-Free, Shared Archive High Priority

Measure Description pdf.png (CMS)

#364. Optimizing Patient Exposure to Ionizing Radiation: Appropriateness: Follow-up CT Imaging for Incidentally Detected Pulmonary Nodules According to Recommended Guidelines High Priority

Measure Description pdf.png (CMS)

#370. Depression Remission at Twelve Months Outcome

Measure Description pdf.png (CMS)

#383. Adherence to Antipsychotic Medications For Individuals with Schizophrenia Outcome

Measure Description pdf.png (CMS)

#384. Adult Primary Rhegmatogenous Retinal Detachment Surgery: No Return to the Operating Room Within 90 Days of Surgery Outcome

Measure Description pdf.png (CMS)

#385. Adult Primary Rhegmatogenous Retinal Detachment Surgery: Visual Acuity Improvement Within 90 Days of Surgery Outcome

Measure Description pdf.png (CMS)

#386. Amyotrophic Lateral Sclerosis (ALS) Patient Care Preferences Outcome

Measure Description pdf.png (CMS)

#387. Annual Hepatitis C Virus (HCV) Screening for Patients who are Active Injection Drug Users

Measure Description pdf.png (CMS)

#388. Cataract Surgery with Intra-Operative Complications (Unplanned Rupture of Posterior Capsule Requiring Unplanned Vitrectomy) Outcome

Measure Description pdf.png (CMS)

#389. Cataract Surgery: Difference Between Planned and Final Refraction Outcome

Measure Description pdf.png (CMS)

#390. Hepatitis C: Discussion and Shared Decision Making Surrounding Treatment Options High Priority

Measure Description pdf.png (CMS)

#391. Follow-Up After Hospitalization for Mental Illness (FUH) High Priority

Measure Description pdf.png (CMS)

#392. HRS-12: Cardiac Tamponade and/or Pericardiocentesis Following Atrial Fibrillation Ablation Outcome

Measure Description pdf.png (CMS)

#393. HRS-9: Infection within 180 Days of Cardiac Implantable Electronic Device (CIED) Implantation, Replacement, or Revision Outcome

Measure Description pdf.png (CMS)

#394.  Immunizations for Adolescents

Measure Description pdf.png (CMS)

#395. Lung Cancer Reporting (Biopsy/Cytology Specimens) Outcome

Measure Description pdf.png (CMS)

#396. Lung Cancer Reporting (Resection Specimens)  Outcome

Measure Description pdf.png (CMS)

#397. Melanoma Reporting Outcome

Measure Description pdf.png (CMS)

#398. Optimal Asthma Control  Outcome

Measure Description pdf.png (CMS)

#400. One-Time Screening for Hepatitis C Virus (HCV) for Patients at Risk

Measure Description pdf.png (CMS)

#401. Hepatitis C: Screening for Hepatocellular Carcinoma (HCC) in Patients with Cirrhosis

Measure Description pdf.png (CMS)

#402.Tobacco Use and Help with Quitting Among Adolescents 

Measure Description pdf.png (CMS)

#403: Adult Kidney Disease: Referral to Hospice High Priority

Measure Description pdf.png (CMS)

#404: Anesthesiology Smoking Abstinence Outcome

Measure Description pdf.png (CMS)

#405: Appropriate Follow-up Imaging for Incidental Abdominal Lesions High Priority

Measure Description pdf.png (CMS)

#406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients High Priority

Measure Description pdf.png (CMS)

#407: Appropriate Treatment of MSSA Bacteremia High Priority

Measure Description pdf.png (CMS)

#408: Opioid Therapy Follow-up Evaluation

Measure Description pdf.png (CMS)

#409: Clinical Outcome Post Endovascular Stroke Treatment Outcome

Measure Description pdf.png (CMS)

#410: Psoriasis: Clinical Response to Oral Systemic or Biologic Medications Outcome

Measure Description pdf.png (CMS)

#411: Depression Remission at Six Months  Outcome

Measure Description pdf.png (CMS)

#412: Documentation of Signed Opioid Treatment Agreement 

Measure Description pdf.png (CMS)

#413: Door to Puncture Time for Endovascular Stroke Treatment Outcome

Measure Description pdf.png (CMS)

#414: Evaluation or Interview for Risk of Opioid Misuse

Measure Description pdf.png (CMS)

#415: Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older High Priority

Measure Description pdf.png (CMS)

#416: Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 through 17 Years High Priority

Measure Description pdf.png (CMS)

#417: Rate of Open Repair of Abdominal Aortic Aneurysms (AAA) Where Patients Are Discharged Alive Outcome

Measure Description pdf.png (CMS)

#418: Osteoporosis Management in Women Who Had a Fracture

Measure Description pdf.png (CMS)

#419: Overuse Of Neuroimaging For Patients With Primary Headache And A Normal Neurological Examination High Priority

Measure Description pdf.png (CMS)

#420: Varicose Vein Treatment with Saphenous Ablation: Outcome Survey

Measure Description pdf.png (CMS)

#421: Appropriate Assessment of Retrievable Inferior Vena Cava Filters for Removal

Measure Description pdf.png (CMS)

#422: Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ Prolapse to Detect Lower Urinary Tract Injury High Priority

Measure Description pdf.png (CMS)

#423: Perioperative Anti-platelet Therapy for Patients undergoing Carotid Endarterectomy

Measure Description pdf.png (CMS)

#424. Perioperative temperature management Outcome

Measure Description pdf.png (CMS)

#425: Photodocumentation of Cecal Intubation

Measure Description pdf.png (CMS)

#426: Post-Anesthetic Transfer of Care Measure: Procedure Room to a Post Anesthesia Care Unit (PACU) High Priority

Measure Description pdf.png (CMS)

#427: Post-Anesthetic Transfer of Care: Use of Checklist or Protocol for Direct Transfer of Care from Procedure Room to Intensive Care Unit (ICU) High Priority

Measure Description pdf.png (CMS)

#428: Pelvic Organ Prolapse: Preoperative Assessment of Occult Stress Urinary Incontinence

Measure Description pdf.png (CMS)

#429: Pelvic Organ Prolapse: Preoperative Screening for Uterine Malignancy High Priority

Measure Description pdf.png (CMS)

#430: Prevention of Post-Operative Nausea and Vomiting (PONV) – Combination Therapy High Priority

Measure Description pdf.png (CMS)

#431: Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling

Measure Description pdf.png (CMS)

#432: Proportion of Patients Sustaining a Bladder Injury at the Time of any Pelvic Organ Prolapse Repair  Outcome

Measure Description pdf.png (CMS)

#433: Proportion of Patients Sustaining a Major Viscus Injury at the time of any Pelvic Organ Prolapse Repair  Outcome

Measure Description pdf.png (CMS)

#434: Proportion of Patients Sustaining a Ureter Injury at the Time of any Pelvic Organ Prolapse Repair Outcome

Measure Description pdf.png (CMS)

#435: Quality of Life Assessment For Patients With Primary Headache Disorders  Outcome

Measure Description pdf.png (CMS)

#436: Radiation Consideration for Adult CT: Utilization of Dose Lowering Techniques 

Measure Description pdf.png (CMS)

#437: Rate of Surgical Conversion from Lower Extremity Endovascular Revascularization Procedure Outcome

Measure Description pdf.png (CMS)

#438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 

Measure Description pdf.png (CMS)

#439: Age Appropriate Screening Colonoscopy  High Priority

Measure Description pdf.png (CMS)

#440: Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma: Biopsy Reporting Time – Pathologist to Clinician  High Priority

Measure Description pdf.png (CMS)

#441: Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control)  Outcome

Measure Description pdf.png (CMS)

#442: Persistence of Beta-Blocker Treatment After a Heart Attack 

Measure Description pdf.png (CMS)

#443: Non-Recommended Cervical Cancer Screening in Adolescent Females  High Priority

Measure Description pdf.png (CMS)

#444: Medication Management for People with Asthma  High Priority

Measure Description pdf.png (CMS)

#445: Risk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG)  Outcome

Measure Description pdf.png (CMS)

#446: Operative Mortality Stratified by the Five STS-EACTS Mortality Categories  Outcome

Measure Description pdf.png (CMS)

#447: Chlamydia Screening and Follow Up 

Measure Description pdf.png (CMS)

#448: Appropriate Workup Prior to Endometrial Ablation  High Priority

Measure Description pdf.png (CMS)

#449: HER2 Negative or Undocumented Breast Cancer Patients Spared Treatment with HER2-Targeted Therapies  High Priority

Measure Description pdf.png (CMS)

#450: Trastuzumab Received By Patients With AJCC Stage I (T1c)–III And HER2 Positive Breast Cancer Receiving Adjuvant Chemotherapy  High Priority

Measure Description pdf.png (CMS)

#451: KRAS Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy 

Measure Description pdf.png (CMS)

#452: Patients with Metastatic Colorectal Cancer and KRAS Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies  High Priority

Measure Description pdf.png (CMS)

#453: Proportion Receiving Chemotherapy in the Last 14 Days of Life  High Priority

Measure Description pdf.png (CMS)

#454: Proportion of Patients who Died from Cancer with more than One Emergency Department Visit in the Last 30 Days of Life 

Measure Description pdf.png (CMS)

#455: Proportion Admitted to the Intensive Care Unit (ICU) in the Last 30 Days of Life  Outcome

Measure Description pdf.png (CMS)

#456: Proportion Not Admitted To Hospice  High Priority

Measure Description pdf.png (CMS)

#457: Proportion Admitted to Hospice for less than 3 days  Outcome

Measure Description pdf.png (CMS)

 

Register with MDinteractive